Exploring GABA - A Receptor Subunit Mutations and Their Role in Epilepsy Pathophysiology

Area of Science:

• Neuroscience
• Genetics
• Computational Biology

Background:

• Epilepsy is characterized by recurrent seizures, often stemming from diminished inhibitory neurotransmission.
• Gamma-aminobutyric acid type A (GABA_A) receptors, specifically the alpha-1 subunit (GABRA1), are crucial for regulating neuronal excitability.
• While GABRA1 variants are associated with epilepsy, their precise molecular mechanisms remain largely unknown.

Purpose of the Study:

• To computationally assess the structural and functional impacts of GABRA1 variants.
• To elucidate the role of these variants in the pathophysiology of epilepsy.

Main Methods:

• Utilized ClinVar to identify 137 GABRA1 missense variants.
• Assessed pathogenicity using ClinPred, REVEL, and FATHMM-XF.
• Performed conservation analysis (ConSurf) and structural modeling (HOPE, UCSF Chimera).

Main Results:

• Eight variants (L49H, P59L, W97R, D99G, G152S, V270G, T294R, P305L) were consistently predicted as deleterious.
• These mutations occurred at conserved residues within extracellular, ligand-binding, and transmembrane domains.
• Structural modeling indicated impaired receptor folding, ligand binding, and ion channel gating, suggesting disrupted GABAergic signaling and potential drug resistance.

Conclusions:

• In silico analysis identified key GABRA1 variants that may contribute to epileptogenesis by altering receptor structure and function.
• These findings support the integration of computational genomics into precision medicine for epilepsy management.